Session Content References

There are many ongoing advances in head and neck cancers in the context of tumor pathologic classification, tumor staging, delivery of established treatment such as radiation and surgery, clinical research on treatment options, and development of novel systemic therapy. All of these elements need to be communicated to and executed by a multidisciplinary team. As knowledge and treatment options and adverse effects of treatment for head and neck cancer have expanded dramatically, clinicians need to increase their knowledge of how to appropriately select and sequence treatments, manage recurrence and late effects, correctly use the updated staging system and appreciate how to incorporate translational research into personalization of therapy in effort to maximize cure-rates and minimize the toxicity of treatments. Failure to stay informed and divergence from evidence-based guidelines leads to lower quality of care by practicing clinicians.

Below is session planning content that will help attendees extend and enhance learning as well as reinforce changes in practice. (View more information on the overall program.)

Oral Cavity
HPV-associated Oropharyngeal Squamous Cell Carcinoma
Tumor Board: Early Stage Disease
Keynote II: Immune-related Therapies and Clinical Trial Updates
Rare Cancers of the Head and Neck
Breakout Session I: Advances in Molecular Imaging
Breakout Session II: Survivorship
Tumor Board: Advanced Disease
Advances in Immunotherapy
De-escalation Debate
Cutaneous Squamous Cell Carcinoma and Carcinoma of Unknown Primary
Copyright © 2021 American Society for Radiation Oncology | Conflict of Interest | Terms of Use | Privacy Policy | Contact Us 
251 18th Street South, 8th Floor, Arlington, VA 22202 | Phone: 703.502.1550 | Fax: 703.502.7852